Pomalidomide plus low-dose dexamethasone in patients with relapsed/refractory multiple myeloma and renal impairment: Results from a phase ii trial

1. Dimopoulos, M.
2. Weisel, K.
3. van de Donk, N.W.C.J.
4. Ramasamy, K.
5. Gamberi, B.
6. Streetly, M.
7. Offidani, M.
8. Bridoux, F.
9. de la Rubia, J.
10. Mateos, M.-V.
11. Ardizzoia, A.
12. Kueenburg, E.
13. Collins, S.
14. Di Micco, A.
15. Rosettani, B.
16. Li, Y.
17. Bacon, P.
18. Sonneveld, P.